These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 38133438)

  • 1. Host Immune Responses to
    Alam MZ; Markantonis JE; Fallon JT
    Trop Med Infect Dis; 2023 Nov; 8(12):. PubMed ID: 38133438
    [No Abstract]   [Full Text] [Related]  

  • 2. Host Immunity and Immunization Strategies for Clostridioides difficile Infection.
    Naz F; Petri WA
    Clin Microbiol Rev; 2023 Jun; 36(2):e0015722. PubMed ID: 37162338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection.
    Sun X; Hirota SA
    Mol Immunol; 2015 Feb; 63(2):193-202. PubMed ID: 25242213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection.
    Khanna S; Assi M; Lee C; Yoho D; Louie T; Knapple W; Aguilar H; Garcia-Diaz J; Wang GP; Berry SM; Marion J; Su X; Braun T; Bancke L; Feuerstadt P
    Drugs; 2022 Oct; 82(15):1527-1538. PubMed ID: 36287379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diluted Fecal Community Transplant Restores Clostridioides difficile Colonization Resistance to Antibiotic-Perturbed Murine Communities.
    Lesniak NA; Tomkovich S; Henry A; Taylor A; Colovas J; Bishop L; McBride K; Schloss PD
    mBio; 2022 Aug; 13(4):e0136422. PubMed ID: 35913161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding host immune responses in
    Wang L; Villafuerte Gálvez JA; Lee C; Wu S; Kelly CP; Chen X; Cao Y
    Imeta; 2024 Jun; 3(3):e200. PubMed ID: 38898983
    [No Abstract]   [Full Text] [Related]  

  • 7. Integrating gut microbiome and host immune markers to understand the pathogenesis of
    Ke S; Pollock NR; Wang XW; Chen X; Daugherty K; Lin Q; Xu H; Garey KW; Gonzales-Luna AJ; Kelly CP; Liu YY
    Gut Microbes; 2021; 13(1):1-18. PubMed ID: 34132169
    [No Abstract]   [Full Text] [Related]  

  • 8. Host Immune Responses to
    Nibbering B; Gerding DN; Kuijper EJ; Zwittink RD; Smits WK
    Front Microbiol; 2021; 12():804949. PubMed ID: 34992590
    [No Abstract]   [Full Text] [Related]  

  • 9. Translational Aspects of the Immunology of Clostridioides difficile Infection: Implications for Pediatric Populations.
    Kociolek LK; Zackular JP; Savidge T
    J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S8-S15. PubMed ID: 34791392
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Markantonis JE; Fallon JT; Madan R; Alam MZ
    Pathogens; 2024 Jan; 13(2):. PubMed ID: 38392856
    [No Abstract]   [Full Text] [Related]  

  • 11. The Effect of Saccharomyces boulardii Primary Prevention on Risk of Hospital-onset Clostridioides difficile Infection in Hospitalized Patients Administered Antibiotics Frequently Associated With C. difficile Infection.
    Wombwell E; Patterson ME; Bransteitter B; Gillen LR
    Clin Infect Dis; 2021 Nov; 73(9):e2512-e2518. PubMed ID: 32575126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ursodeoxycholic Acid (UDCA) Mitigates the Host Inflammatory Response during Clostridioides difficile Infection by Altering Gut Bile Acids.
    Winston JA; Rivera AJ; Cai J; Thanissery R; Montgomery SA; Patterson AD; Theriot CM
    Infect Immun; 2020 May; 88(6):. PubMed ID: 32205405
    [No Abstract]   [Full Text] [Related]  

  • 13. Intestinal Inflammation Reversibly Alters the Microbiota to Drive Susceptibility to Clostridioides difficile Colonization in a Mouse Model of Colitis.
    Barron MR; Sovacool KL; Abernathy-Close L; Vendrov KC; Standke AK; Bergin IL; Schloss PD; Young VB
    mBio; 2022 Aug; 13(4):e0190422. PubMed ID: 35900107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Faecal microbiota transplantation in the treatment of recurrent intestinal Clostridioides difficile infection - a ten-year single-center experience.
    Pipek B; Valentová H; Fojtík P; Urban O
    Cas Lek Cesk; 2022; 161(3-4):126-130. PubMed ID: 36100450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biofilm Formation of
    Dicks LMT
    Microorganisms; 2023 Aug; 11(9):. PubMed ID: 37764005
    [No Abstract]   [Full Text] [Related]  

  • 16. Type 3 Immunity during Clostridioides difficile Infection: Too Much of a Good Thing?
    Saleh MM; Petri WA
    Infect Immun; 2019 Dec; 88(1):. PubMed ID: 31570564
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunization Strategies Against Clostridioides difficile.
    Campidelli C; Bruxelle JF; Collignon A; Péchiné S
    Adv Exp Med Biol; 2024; 1435():117-150. PubMed ID: 38175474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Gut Bacterial Community Potentiates Clostridioides difficile Infection Severity.
    Lesniak NA; Schubert AM; Flynn KJ; Leslie JL; Sinani H; Bergin IL; Young VB; Schloss PD
    mBio; 2022 Aug; 13(4):e0118322. PubMed ID: 35856563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient Experiences with Clostridioides difficile Infection and Its Treatment: A Systematic Literature Review.
    Armstrong EP; Malone DC; Franic DM; Pham SV; Gratie D; Amin A
    Infect Dis Ther; 2023 Jul; 12(7):1775-1795. PubMed ID: 37395984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The host immune response to Clostridium difficile.
    Kelly CP; Kyne L
    J Med Microbiol; 2011 Aug; 60(Pt 8):1070-1079. PubMed ID: 21415200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.